Watermark
  Back to Search Results

BGB-290-201

Completed

Efficacy and Safety of BGB-290 in the Treatment of Metastatic HER2-Negative Breast Cancer Patients With BRCA Mutation in China

BeOne Study ID Info icon SVG graphic used for tooltips or additional information.

BGB-290-201

ClinicalTrials.gov ID Info icon SVG graphic used for tooltips or additional information.

NCT03575065

China Drug Trials ID Info icon SVG graphic used for tooltips or additional information.

CTR20171623

Study Overview

Sex: All Info icon SVG graphic used for tooltips or additional information.

Age: 18 Years / N/A

Accepts Healthy Volunteers? No

Study Documents

Study Protocol Statistical Analysis Plan

Study Overview

Sex: All Info icon SVG graphic used for tooltips or additional information.

Age: 18 Years / N/A

Accepts Healthy Volunteers? No

Study Documents

Study Protocol Statistical Analysis Plan